NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT NRX PHARMACEUTICALS INC.

NRX Pharmaceuticals Inc. (NASDAQ: NRXP)
Listen to this Section


$2.81
-0.0300 ( -0.18% ) 1.8K

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market Data


Open $2.81
Previous Close $2.84
Volume 1.8K
Market Cap $48.04M
Day Range $2.82 - $2.85
52 Week Range $1.10 - $7.33
Shares Outstanding 16.92M
Change % -0.18%
Net Change ▼ -0.0300
Insider Ownership 0.00%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2021
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 445,000.00

Date Type Amount Purchased Purchaser
2024-12-18 Buy 40000.00 Javitt Jonathan C
2023-09-11 Buy 70000.00 Hurvitz Chaim
2023-09-11 Buy 35000.00 Gorovitz Aaron
2023-08-24 Buy 100000.00 Javitt Jonathan C
2023-08-23 Buy 200000.00 Javitt Jonathan C

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Feb 02, 2024

Latest News


× Before browsing our site, please accept our cookies policy